Tetracyclines + Sulfa + Misc - SOA Flashcards

1
Q

List the tetracyclines:

A
  • tetracycline
  • doxycycline
  • minocycline
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

List the tetracycline analogs:

A
  • tigecycline
  • eravacycline
  • omadacycline
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the mechanism of action of the tetracyclines and tetracycline analogs?

  • tetracycline, doxycycline, minocycline
  • tigecycline, eravacycline, omadacycline
A

The tetracyclines inhibit protein synthesis by binding to 30S ribosomal subunits.

Blocks the binding of amino-acyl tRNA to the A site on the mRNA-ribosomal complex

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What kind of activity do the tetracyclines and analogs display?

A
  • bacteriostatic
  • time-dependent
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the mechanisms of resistance against tetracyclines?

tetracycline, doxycycline, minocycline

A
  1. tetracycline efflux pumps that decrease accumulation within the bacteria
  2. ribosomal protection proteins that prevent the drug from getting to the ribosome
  3. enzymatic inactivation of the tetracycline

The first two are most common and more important

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Why do the tetracycline analogs retain activity against many tetracycline-resistant bacteria?

tigecycline, eravacyline, omadacycline

A

They are not affected by the two main tetracycline resistance mechanisms.

efflux and ribosomal protection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the general SOA of the tetracyclines?

tetracycline, doxycycline, minocycline

A
  • some GP
  • some GN
  • some anaerobes
  • some atypicals

Emergence of resistance and better abx have limited their usefulness.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What target organisms do the tetracyclines cover?

tetracycline, doxycycline, minocycline

A
  • MSSA
  • MRSA
  • Legionella

One of the three classes that covers legionella

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the general SOA of the tetracycline analogs?

tigecycline, eravacycline, omadacycline

A
  • broad range of GP, GN
  • aerobes and anaerobes
  • some atypicals
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What target organisms do the tetracycline analogs cover?

A
  • MSSA
  • MRSA
  • BDA

Do not cover P. mirabilis nor p. aeruginosa

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What impairs absorption of PO tetracyclines and analogs?

tertra, doxy, mino, omada

A
  • Absorption of the oral tetracyclines and omadacycline is impaired by the concurrent ingestion of dairy, aluminum hydroxide gels, calcium, magnesium, iron, zinc, and bismuth subsalicylate due to the chelation with divalent or trivalent cations.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

How are tetracyclines and analogs distributed?

A
  • widely distributed
  • gets into prostatic fluids
  • do not get into CSF
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

How is tetracycline eliminated?

dose adjustment?

A
  • excreted unchanged in the urine via glomerular filtration
  • requires dosage adjustment in renal dysfunction
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

How are doxycycline and minocycline eliminated?

dose adjustment?

A
  • excreted by nonrenal routes
  • do not require dosage adjustment in renal dysfunction
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

How are the tetracycline analogs eliminated?

dose adjustment?

A
  • The analogs are eliminated by biliary/fecal excretion and some unchanged drug gets excreted in the urine
  • None of the analogs require dose adjustments in renal dysfunction nor patients receiving HD
  • Tigecycline and eravacycline require dose adjustments in patients with severe hepatic impairment
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are the clinical uses for the tetracyclines?

mainly doxy

A
  • outpatient community acquired pneumonia
  • chlamydia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What are the adverse effects of the tetracyclines and analogs?

A
  • GI
  • dermatologic - photosensitivity
  • teeth discoloration in developing teeth, decreased bone growth
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Why are the tetracyclines and analogs contraindicated in pregnancy, lactating, and young children (<8 years)?

A
  • They cause permanent discoloration of teeth
  • They form a complex in bone-forming tissue leading to decreased bone growth
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q
  • What is the mechanism of action of sulfamethoxazole?
  • What is the mechanism of action of trimethorpim?
A
  • sulfamethoxazole competitively inhibits PABA by inhibiting dihydropteroate synthetase
  • trimethoprim competitively inhibits the activity of bacterial dihydrofolate reductase

They both produce sequential blockade of microbial folic acid synthesis which then inhibits DNA production.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What kind of activity does TMP-SMX display?

A
  • time-dependent
  • bactericidal
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What is the resistance mechanism to SMX-TMP?

A
  • Mutation in dihydropteroate synthase or dihydrofolate reductase
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What is the general SOA of TMP-SMX?

A
  • some GP aerobes
  • great activity for GN aerobes
  • no anaerobes
  • pneumocystis carinii/jirovecii
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What target organisms does TMP-SMX cover?

A
  • MSSA
  • MRSA

TMP-SMX is NOT active against pseudomonas aeruginosa

24
Q

What is TMP-SMX the drug of choice for?

A

pneumocystis carinii/jirovecii

25
Q

What ratio of TMP-SMX is needed to achieve the optimal synergistic ratio of serum concentrations?

serum concentration ratio should be 1:20

A

A fixed oral or IV combination of 1:5 is needed.

26
Q

Describe the pharmacokinetics of TMP-SMX:

absorption, distribution, elimination

A
  • TMP-SMX is rapidly and well absorbed after oral administration
  • It concentrates in most tissues including CSF, urine, and uninflamed prostatic tissue.
  • SMX is 70% protein bound
  • excreted in the urine
  • Requires dose adjustment in patients with CrCl< 30 mL/min
27
Q

What are the clinical uses for TMP-SMX?

A
  • UTI
  • bacterial prostatitis
  • pneumocystis carinii pneumonia (prophylaxis and treatment)
28
Q

What are the adverse effects from TMP-SMX?

A
  • leukopenia, thrombocytopenia
  • hypersensitivity, rash
  • renal insufficiency
  • crystalluria
29
Q

What drug interactions can TMP-SMX cause?

A

TMP-SMX can potentiate the anticoagulant effects of warfarin.

30
Q

Why can’t TMP-SMX be used in pregnant or lactating women?

A

It may cause kernicterus (jaundice) in the newborn due to bilirubin displacement from protein binding sites

31
Q

List the polymyxins:

A
  • polymyxin B
  • colistin
32
Q

What is the mechanism of action of the polymyxins?

polymyxin B, colisitin

A

They are cationic detergents that bind to the anionic phospholipids in the cell membrane which causes displacement of Ca and Mg. This displacement leads to changes in cell wall permeability and leakage of cellular contents –> which leads to cell death.

33
Q

What kind of activity do the polymyxins display?

A
  • concentration dependent
  • bactericidal
34
Q

What is the mechanism of resistance against the polymyxins?

A

Alteration in outer cell membrane

  • decrease in calcium or magnesium
  • decrease in lipopolysaccharide content
  • decrease in membrane proteins
35
Q

What is the general SOA of the polymyxins?

A
  • ONLY active against GN aerobes
  • NOTHING ELSE
36
Q

What target organisms do the polymyxins cover?

A

Pseudomonas aeruginosa

37
Q

Describe the absorption and elimination for the polymyxins:

A
  • polymyxins are not absorbed from the GI tract
  • small distribution
  • polymyxin B and colistin are eliminated by nonrenal routes
  • they do not require dosage adjustments in renal dysfunction

  • CMS (colistin methanesulfate prodrug) is excreted in the urine and DOES require dose adjustment for CrCl< 80 mL/min
38
Q

What are the clinical uses for the polymyxins?

A
  • polymyxin B is good for GN systemic infections
  • colistin is preferred for UTIs
39
Q

What are the adverse effects of the polymyxins?

A
  • nephrotoxicity - tubular necrosis
  • neurotoxicity - paresthesia
40
Q

What is the mechanism of action of clindamycin?

A

Clindamycin inhibits protein synthesis by binding to 50S ribosomal subunits

41
Q

What is the mechanism of resistance against clindamycin?

A

Alteration in ribosomal binding site – coded by erm

42
Q

What kind of activity does clindamycin display?

A
  • time-dependent
  • bacteriostatic
43
Q

What is the general SOA of clindamycin?

A
  • some GP
  • NO GN
  • anaerobes
  • BDA
44
Q

What target organisms does clindamycin cover?

A
  • MSSA
  • CA-MRSA
  • BDA
45
Q

What does clindamycin induce?

46
Q

Describe the pharmacokinetics of clindamycin?

A
  • rapidly and well absorbed after oral administration
  • penetrates most body tissues (including bone)
  • does NOT penetrate CSF
  • metabolized by the liver
  • enterohepatic circulation prolongs presence in the stool
  • half-life is prolonged in liver dysfunction
47
Q

What are the clinical uses for clindamycin?

A
  • diabetic foot infections
  • anaerobic infections outside of CNS
  • alternative agent for GP infections for patients allergic to penicillins
48
Q

What are the adverse effects of clindamycin?

A
  • GI
  • C. diff colitis
  • hepatotoxicity
49
Q

What is the mechanism of action of metronidazole?

A

Metronidazole is a prodrug activated by ferredoxins whose activated metabolites damage bacterial DNA

50
Q

What are the mechanisms of resistance to metronidazole?

A
  • altered growth requirements
  • reduced transcription of ferredoxin gene

If the organism grows in higher oxygen concentrations, metronidazole is less likely to be activated

51
Q

What kind of activity does metronidazole display?

A
  • concentration-dependent
  • rapidly bactericidal
52
Q

What is the general SOA of metronidazole?

Which target organisms does it cover?

A
  • NO AEROBES
  • ADA
  • BDA
  • C. diff
53
Q

Describe the pharmacokinetics of metronidazole:

A
  • rapidly and completely absorbed after oral administration
  • well distributed
  • penetrates into the CSF and brain tissue
  • metabolized by liver to active metabolites
  • excreted in the urine and feces
  • dosage adjustments are no longer required
  • removed during hemodialysis
54
Q

What is metronidazole used for clinically?

A

Pseudomembranous colitis due to C. Diff

55
Q

What are the adverse effects of metronidazole?

A
  • GI
  • metallic taste
  • CNS - peripheral neuropathy
  • may be teratogenic

Avoid during first trimester and breastfeeding

56
Q

What are the drug interactions with metronidazole?

A
  • increased activity of warfarin
  • alcohol –> disulfram reaction